Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Esophageal Cancer Research and Treatment, and Breast Implant and Reconstruction.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology2023cited by 599position: middledoi